Search

Your search keyword '"Cero, Cheryl"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Cero, Cheryl" Remove constraint Author: "Cero, Cheryl"
111 results on '"Cero, Cheryl"'

Search Results

2. Targeted and selective knockout of the TLQP-21 neuropeptide unmasks its unique role in energy homeostasis

4. Standardized In Vitro Models of Human Adipose Tissue Reveal Metabolic Flexibility in Brown Adipocyte Thermogenesis

5. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

8. m6A mRNA Methylation in Brown Adipose Tissue Regulates Systemic Insulin Sensitivity via an Inter-Organ Prostaglandin Signaling Axis

10. Targeted and selective knockout of the TLQP-21 neuropeptide unmasks its unique role in energy homeostasis

15. Psychosocial stress induces hyperphagia and exacerbates diet-induced insulin resistance and the manifestations of the Metabolic Syndrome

17. VGF-Derived Peptide TLQP-21

19. Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis

20. Lipolysis drives expression of the constitutively active receptor GPR3 to induce adipose thermogenesis

21. Identification and characterization of distinct brown adipocyte subtypes in C57BL/6J mice

22. Epigenetic Signatures of Human Myocardium and Brown Adipose Tissue Revealed with Simultaneous Positron Emission Tomography and Magnetic Resonance of Class I Histone Deacetylases

23. Identification and characterization of distinct brown adipocyte subtypes in C57BL/6J mice

24. Identification and characterization of distinct murine brown adipocyte lineages

29. Chronic mirabegron treatment increases human brown fat, HDL cholesterol, and insulin sensitivity

30. Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity

31. Combining a β3 adrenergic receptor agonist with alpha‐lipoic acid reduces inflammation in male mice with diet‐induced obesity.

32. Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21

34. Peptide/Receptor Evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21

35. Regulation of Human Adipose Tissue Activation, Gallbladder Size, and Bile Acid Metabolism by a β3-Adrenergic Receptor Agonist

40. Molecular mechanisms and individual vulnerability in an animal model (Mus musculus) of obesity induced by chronic social stress

42. The TLQP-21 Peptide Activates the G-Protein-Coupled Receptor C3aR1 via a Folding-upon-Binding Mechanism

43. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure

45. Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21

47. Mechanisms of the pro-lipolytic and anti-obesity effects of the VGF-derived peptide TLQP-21

48. Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity.

49. m 6 A mRNA Methylation in Brown Adipose Tissue Regulates Systemic Insulin Sensitivity via an Inter-Organ Prostaglandin Signaling Axis.

50. Targeted and selective knockout of the TLQP-21 neuropeptide unmasks its unique role in energy homeostasis.

Catalog

Books, media, physical & digital resources